Remove 2021 Remove Allergic Reactions Remove EMS
article thumbnail

EM@3AM: Leukopenia

EMDocs

Well keep it short, while you keep that EM brain sharp. Available from: [link] The post EM@3AM: Leukopenia appeared first on emDOCs.net - Emergency Medicine Education. 10^9/L) Moderate (0.50.9 10^9/L) Severe (< 0.5 10^9/L) Generalized leukopenia (i.e. Most common causes of leukopenia Infections: 36.4% Medications: 25.6%

EMS 95
article thumbnail

EM@3AM: Traumatic Iritis

EMDocs

We’ll keep it short, while you keep that EM brain sharp. Dilation of conjunctival vessels resulting in hyperemia and edema (A) is the underlying pathophysiology of conjunctivitis, which can be brought on by infection or allergic reaction. 2021 Oct 7. Merck Manuals Professional Edition , Merck Manuals, 12 Nov. and John O.

EMS 98
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

ToxCard: Crotalid Envenomation Part 2 – CroFab vs. AnaVip: What’s the Difference?

EMDocs

In April 2021, after a post-hoc analysis of the original phase 3 study suggested non-inferiority of the F(ab’) 2 antivenin against copperhead envenomation, the FDA expanded approval of this antivenom to include copperhead and cottonmouth envenomations. Published online April 2021. Ann Emerg Med. 2020;76(4):S29. Accessed May 7, 2022.

article thumbnail

What the Emergency Clinician Must Know about Remote Monitors in Heart Failure

EMDocs

10 This procedure has well-described rare complications including infection, blood loss, allergic reaction, arrhythmia, pneumothorax if approaching via the internal jugular vein, embolization of the device, and pulmonary artery perforation or dissection. 2021 Jan;14(1):e008693. 8 The device itself is 2 x 2.5 doi: 10.1161/CIRCEP.120.008693.

article thumbnail

The PALACE Trial: Direct Oral PCN Challenge in Patients with Low-Risk PCN Allergy?

RebelEM

What They Did: Parallel, 2-arm, noninferiority, open-label, multicenter, international randomized clinical trial Occurred in 6 specialized centers (3 in North America – US & Canada and 3 Outside of North America – Australia) Trial took place from June 2021 to December 2022 Used PEN-FAST to risk stratify patients.

article thumbnail

CT Angiography Head and Neck: Indications and Limitations

EMDocs

Authors: Mary Hamblen, DO (EM Resident Physician, TX); Justin Hacnik, MD (EM Resident Physician, TX); Katherine Spencer, MD (EM Resident Physician, TX); J.D. RadioGraphics 2021, 41 (3), E81-E89. Aging Dis 2021, 12 (4), 1000-1009. AJNR Am J Neuroradiol 2021, 42 (4), 743-748. Heilbrun, M. DOI: 10.1148/rg.2021200107.

Stroke 105